HPK1-IN-2 is a novel,potent and orally active hematopoietic progenitor kinase-1 (HPK1) inhibitor (IC50<0.05 μΜ) with antitumor activity. HPKl-IN-2 is now viewed as a possible target for therapeutic intervention. It has been reported that HPKl-IN-2 can be a novel target for cancer immunotherapy.

纯度：≥98%

CAS： 2056122-11-1